Hans-Jürgen Staab

Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma

Hans-Jürgen Staab, F. A. Anderer, T. Brümmendorf et al. · British Journal of Cancer · 1981 · 69 citations · Full text

Prognostic Biomarkers, Surgical Oncology, Medicine +9

Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer

Hans-Jürgen Staab, F. A. Anderer, A. Hornung et al. · British Journal of Cancer · 1982 · 64 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +7

Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract?

Hans-Jürgen Staab, F. A. Anderer, E. Stumpf et al. · British Journal of Cancer · 1980 · 27 citations

Prognostic Marker, Prognostic Biomarkers, Medicine +10

Subnuclear distribution of DNA topoisomerase I and Bax protein in normal and xeroderma pigmentosum fibroblasts after irradiation with UV light and c rays or treatment with topotecan

Heinz Walter Thielmann, Odilia Popanda, Hans-Jürgen Staab · Journal of Cancer Research and Clinical Oncology · 1999 · 21 citations · Full text

Chromatin, C Rays, Natural Sciences +9

Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)

Ulf Seifart, Katrin Jensen, J. Ukena et al. · Lung Cancer · 2005 · 19 citations

Medicine, Phase Ii Study, Bronchial Neoplasm +7